Literature DB >> 35416478

Predictive validity of the Edinburgh postnatal depression scale and other tools for screening depression in pregnant and postpartum women: a systematic review and meta-analysis.

Seong-Hi Park1, Jeung-Im Kim2.   

Abstract

PURPOSE: To compare the predictive validity of the Edinburgh Postnatal Depression Scale (EPDS) and other tools for screening depression in pregnant and postpartum women through a systematic review and meta-analysis.
METHODS: An electronic search of MEDLINE, EMBASE, CINAHL, and PsycArticles databases was conducted using the following keywords: depression, perinatal-related terms, and EPDS. Quality Assessment of Diagnostic Accuracy Studies-2 was used to assess the risk of bias in diagnostic studies.
RESULTS: The search identified 823 articles, of which 17 studies met the inclusion criteria. In 1831 pregnant women from nine studies, pooled sensitivity and specificity of the EPDS were 0.81 and 0.87, respectively, with summary receiver operating characteristic (sROC) curve of 0.90. In 515 postpartum women from six studies, pooled sensitivity, specificity, and sROC were 0.79, 0.92, and 0.90, respectively. We then compared the EPDS with other tools using three or more studies. The sROC curve of the Patient Health Questionnaire-9 was 0.74, which was lower than that (0.86) of the EPDS. The sROC curve of the Beck Depression Inventory and the ten-item Kessler Psychological Distress Scale was 0.91, similar to that of the EPDS (0.90 and 0.87). However, in comparison with the Postpartum Depression Screening Scale (0.98), the sROC curve of the EPDS was 0.54.
CONCLUSION: As a tool specialized for screening depression in pregnant and postpartum women, the EPDS showed excellent performance. Thus, the EPDS can be used in preference to other tools to screen for depression in perinatal women at a primary care setting or a midwifery center.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Depression; Postpartum depression; Pregnant women; Sensitivity and specificity; Systematic review

Year:  2022        PMID: 35416478     DOI: 10.1007/s00404-022-06525-0

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

1.  Genetic variants in the genes of the sex steroid hormone metabolism and depressive symptoms during and after pregnancy.

Authors:  Michael O Schneider; Jutta Pretscher; Tamme W Goecke; Lothar Häberle; Anne Engel; Johannes Kornhuber; Anna Eichler; Arif B Ekici; Matthias W Beckmann; Peter A Fasching; Eva Schwenke
Journal:  Arch Gynecol Obstet       Date:  2022-06-10       Impact factor: 2.344

2.  Perinatal depression screening and prevention: Descriptive findings from a multicentric program in the South of Italy.

Authors:  Antonello Bellomo; Melania Severo; Annamaria Petito; Luigi Nappi; Salvatore Iuso; Mario Altamura; Alessia Marconcini; Elisa Giannaccari; Giuseppe Maruotti; Giuseppe Luigi Palma; Mario Vicino; Antonio Perrone; Anna Maria Tufariello; Valeria Sannicandro; Eleonora Milano; Giulia Arcidiacono; Melanie Di Salvatore; Antonella Caroli; Isabella Di Pinto; Antonio Ventriglio
Journal:  Front Psychiatry       Date:  2022-08-05       Impact factor: 5.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.